0001679768-16-000003.txt : 20161123 0001679768-16-000003.hdr.sgml : 20161123 20161123161454 ACCESSION NUMBER: 0001679768-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161123 DATE AS OF CHANGE: 20161123 EFFECTIVENESS DATE: 20161123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroRx, Inc. CENTRAL INDEX KEY: 0001679768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275113 FILM NUMBER: 162016759 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET, SUITE 600 STREET 2: ONE COMMERCE CENTER CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 212-643-0417 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET, SUITE 600 STREET 2: ONE COMMERCE CENTER CITY: WILMINGTON STATE: DE ZIP: 19801 D 1 primary_doc.xml X0707 D LIVE 0001679768 NeuroRx, Inc. 1201 Orange Street, Suite 600 One Commerce Center WILMINGTON DE DELAWARE 19801 212-643-0417 DELAWARE None None Corporation true 2015 Jonathan Javitt 913 North Market Street, Suite 200 c/o NeuroRx, Inc. Wilmington DE DELAWARE 19801 Executive Officer Director Daniel Javitt 800 Park Avenue Fort Lee NJ NEW JERSEY 07024 Director James Lawrence 4415 E. Lake Harriet Parkway Minneapolis MN MINNESOTA 55419 Director Chaim Hurvitz 31 Yavneh Street c/o Shirat HaChaim Ltd. Tel Aviv L3 ISRAEL 65792 Director Sherry Glied 430 West 116th St., 7E New York NY NEW YORK 10027 Director Pharmaceuticals Decline to Disclose 06b false 2016-11-10 false true false 1500 2159687 2159687 0 All amounts sold were sold in a previous convertible note offering. Most note holders have converted their convertible notes to equity in this offering. false 16 0 0 0 false NeuroRx, Inc. Jonathon Pelter Jonathon Pelter Authorized Signatory 2016-11-21